Aspire Biopharma (ASBP) Competitors $0.35 +0.03 (+10.10%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFDA EventsOwnershipSEC FilingsTrendsBuy This Stock ASBP vs. CLSD, ASRT, OTLK, IRD, IKNA, RPTX, UNCY, PMVP, CNTB, and CRVOShould you be buying Aspire Biopharma stock or one of its competitors? The main competitors of Aspire Biopharma include Clearside Biomedical (CLSD), Assertio (ASRT), Oncobiologics (OTLK), Opus Genetics (IRD), Ikena Oncology (IKNA), Repare Therapeutics (RPTX), Unicycive Therapeutics (UNCY), PMV Pharmaceuticals (PMVP), Connect Biopharma (CNTB), and CervoMed (CRVO). These companies are all part of the "pharmaceutical products" industry. Aspire Biopharma vs. Its Competitors Clearside Biomedical Assertio Oncobiologics Opus Genetics Ikena Oncology Repare Therapeutics Unicycive Therapeutics PMV Pharmaceuticals Connect Biopharma CervoMed Aspire Biopharma (NASDAQ:ASBP) and Clearside Biomedical (NASDAQ:CLSD) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability. Do institutionals and insiders have more ownership in ASBP or CLSD? 19.2% of Aspire Biopharma shares are owned by institutional investors. Comparatively, 18.8% of Clearside Biomedical shares are owned by institutional investors. 48.0% of Aspire Biopharma shares are owned by insiders. Comparatively, 6.2% of Clearside Biomedical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more risk & volatility, ASBP or CLSD? Aspire Biopharma has a beta of 0.74, suggesting that its stock price is 26% less volatile than the S&P 500. Comparatively, Clearside Biomedical has a beta of 2.05, suggesting that its stock price is 105% more volatile than the S&P 500. Is ASBP or CLSD more profitable? Aspire Biopharma has a net margin of 0.00% compared to Clearside Biomedical's net margin of -818.57%. Company Net Margins Return on Equity Return on Assets Aspire BiopharmaN/A N/A -508.70% Clearside Biomedical -818.57%N/A -114.23% Does the media prefer ASBP or CLSD? In the previous week, Aspire Biopharma and Aspire Biopharma both had 1 articles in the media. Clearside Biomedical's average media sentiment score of 1.89 beat Aspire Biopharma's score of 0.43 indicating that Clearside Biomedical is being referred to more favorably in the news media. Company Overall Sentiment Aspire Biopharma Neutral Clearside Biomedical Very Positive Which has preferable valuation and earnings, ASBP or CLSD? Aspire Biopharma has higher earnings, but lower revenue than Clearside Biomedical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAspire BiopharmaN/AN/A-$12.54MN/AN/AClearside Biomedical$1.66M39.14-$34.35M-$0.41-2.04 Do analysts prefer ASBP or CLSD? Clearside Biomedical has a consensus target price of $4.75, indicating a potential upside of 468.18%. Given Clearside Biomedical's stronger consensus rating and higher possible upside, analysts plainly believe Clearside Biomedical is more favorable than Aspire Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aspire Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Clearside Biomedical 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryClearside Biomedical beats Aspire Biopharma on 7 of the 11 factors compared between the two stocks. Get Aspire Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ASBP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ASBP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASBP vs. The Competition Export to ExcelMetricAspire BiopharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.74M$2.91B$5.52B$9.32BDividend YieldN/A2.46%4.25%4.05%P/E RatioN/A20.3628.1519.68Price / SalesN/A302.56437.63100.28Price / CashN/A42.3835.5357.53Price / Book-0.167.768.235.67Net Income-$12.54M-$55.11M$3.23B$257.51M7 Day Performance7.36%0.95%-0.01%0.52%1 Month Performance-0.82%8.44%5.61%8.84%1 Year PerformanceN/A-2.38%26.52%14.18% Aspire Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASBPAspire BiopharmaN/A$0.35+10.1%N/AN/A$15.74MN/A0.00N/AGap UpCLSDClearside Biomedical2.0587 of 5 stars$0.88+1.1%$4.75+436.8%-33.3%$68.03M$1.66M-2.1630Positive NewsASRTAssertio1.8321 of 5 stars$0.69-2.7%$2.75+298.0%-57.1%$68.01M$124.96M-2.1620News CoverageOTLKOncobiologics2.503 of 5 stars$2.07+2.5%$9.60+363.8%-73.1%$67.81MN/A-2.2720Gap UpIRDOpus Genetics1.8458 of 5 stars$1.13+0.9%$7.33+549.0%N/A$67.42M$13.65M-0.5414IKNAIkena Oncology2.732 of 5 stars$1.38-0.7%$3.00+117.4%-16.5%$67.08M$9.16M-1.6070News CoverageGap DownRPTXRepare Therapeutics2.7529 of 5 stars$1.50-3.8%$4.50+200.0%-60.3%$66.91M$53.48M-0.50180News CoverageGap UpUNCYUnicycive Therapeutics2.9751 of 5 stars$5.01-4.6%$60.00+1,097.6%-7.4%$66.36M$680K-0.989High Trading VolumePMVPPMV Pharmaceuticals3.1554 of 5 stars$1.26-0.8%$5.50+336.5%-18.4%$65.98MN/A-1.0750Positive NewsCNTBConnect Biopharma3.1081 of 5 stars$1.52+32.2%$7.00+360.5%+15.9%$63.90M$26.03M0.00110Gap UpHigh Trading VolumeCRVOCervoMed3.2675 of 5 stars$7.15-0.8%$22.57+215.7%-59.9%$62.75M$9.74M-3.284News CoveragePositive NewsGap Up Related Companies and Tools Related Companies CLSD Alternatives ASRT Alternatives OTLK Alternatives IRD Alternatives IKNA Alternatives RPTX Alternatives UNCY Alternatives PMVP Alternatives CNTB Alternatives CRVO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ASBP) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredFirst time revealing what I do with my own moneyMy mom has made 3,400% returns - here’s her 3-Stock Secret' Joel Litman is an accountant. So is his mom, wh...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aspire Biopharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aspire Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ASBP Stock Alerts